Cardiotoxicity in Oncology Guidelines: Discrepancies Do Matter.
- Resource Type
- Editorial & Opinion
- Authors
- Tan S; Victorian Heart Institute, Monash University, Melbourne, Vic, Australia; Monash Heart, Victorian Heart Hospital, Melbourne, Vic, Australia. Electronic address: sean.tan@monash.edu.; Kader Z; Monash Heart, Victorian Heart Hospital, Melbourne, Vic, Australia.; Day D; School of Clinical Sciences at Monash Health, Monash University, Melbourne, Vic, Australia; Department of Oncology, Monash Health, Melbourne, Vic, Australia.; Chen D; Prince of Wales and St George Hospitals, South Eastern Sydney Local Health District, Sydney, NSW, Australia; Hatter Cardiovascular Institute, University College of London, London, UK.; Nicholls SJ; Victorian Heart Institute, Monash University, Melbourne, Vic, Australia; Monash Heart, Victorian Heart Hospital, Melbourne, Vic, Australia.; Ramkumar S; Victorian Heart Institute, Monash University, Melbourne, Vic, Australia; Monash Heart, Victorian Heart Hospital, Melbourne, Vic, Australia.
- Source
- Publisher: Elsevier Australia Country of Publication: Australia NLM ID: 100963739 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1444-2892 (Electronic) Linking ISSN: 14439506 NLM ISO Abbreviation: Heart Lung Circ Subsets: MEDLINE
- Subject
- Language
- English
Competing Interests: Conflicts of Interest DD is an eviQ reference committee member but was not involved in the development of recommendations for cardiac monitoring for cancer therapy-related cardiac dysfunction. The remaining authors have no conflicts of interest to disclose.